| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atherosclerosis and Lipoproteins |
From the Division of Cardiovascular and Respiratory Medicine, Department of Internal Medicine (T.T., K.H., T. Yamashita, M.S., N.S., N.I., M.Y., S.K.), Kobe University Graduate School of Medicine, Kobe, Japan; the Department of Medical Engineering and Systems Cardiology (T. Yada, M.G.), Kawasaki Medical School, Kurashiki, Japan; the Department of Geriatrics (A.F., T.H.), Nagoya University Graduate School of Medicine, Nagoya, Japan; the Department of Cardiovascular Medicine (N.J.A., K.M.C.), University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom; and the Department of General Medicine (S.K.), Saiseikai Nakatsu Hospital, Osaka, Japan.
Correspondence to Seinosuke Kawashima MD, PhD, Department of General Medicine, Saiseikai Nakatsu Hospital, 2-10-39, Shibata, Kita-ku, Osaka, 530-0012, Japan. E-mail kawashima1008{at}nakatsu.saiseikai.or.jp
Objective When the availability of tetrahydrobiopterin (BH4) is deficient, endothelial nitric oxide synthase (eNOS) produces superoxide rather than NO (uncoupled eNOS). We have shown that the atherosclerotic lesion size was augmented in apolipoprotein Edeficient (ApoE-KO) mice overexpressing eNOS because of the enhanced superoxide production. In this study, we addressed the specific importance of uncoupled eNOS in atherosclerosis, and the potential mechanistic role for specific versus nonspecific antioxidant strategies in restoring eNOS coupling.
Methods and Results We crossed mice overexpressing eNOS in the endothelium (eNOS-Tg) with mice overexpressing GTP-cyclohydrolase I (GCH), the rate-limiting enzyme in BH4 synthesis, to generate ApoE-KO/eNOS-Tg/GCH-Tg mice. As a comparison, ApoE-KO/eNOS-Tg mice were treated with vitamin C. Atherosclerotic lesion formation was increased in ApoE-KO/eNOS-Tg mice compared with ApoE-KO mice. GCH overexpression in ApoE-KO/eNOS-Tg/GCH-Tg mice increased vascular BH4 levels and reduced plaque area. This reduction was associated with decreased superoxide production from uncoupled eNOS. Vitamin C treatment failed to reduce atherosclerotic lesion size in ApoE-KO/eNOS-Tg mice, despite reducing overall vascular superoxide production.
Conclusion In contrast to vitamin C treatment, augmenting BH4 levels in the endothelium by GCH overexpression reduced the accelerated atherosclerotic lesion formation in ApoE-KO/eNOS-Tg mice, associated with a reduction of superoxide production from uncoupled eNOS.
In apolipoprotein Edeficient mice overexpressing eNOS in the endothelium, augmenting BH4 levels in the endothelium by GTP-cyclohydrolase I overexpression was more efficient to reduce the accelerated atherosclerotic lesion formation and superoxide production from uncoupled eNOS compared with chronic vitamin C treatment.
Key Words: eNOS uncoupling tetrahydrobiopterin vitamin C atherosclerosis apolipoprotein Edeficient mice
Related Article:
Arterioscler. Thromb. Vasc. Biol. 2007 27: 1493-1495.
This article has been cited by other articles:
![]() |
A. Takaki, K. Morikawa, M. Tsutsui, Y. Murayama, E. Tekes, H. Yamagishi, J. Ohashi, T. Yada, N. Yanagihara, and H. Shimokawa Crucial role of nitric oxide synthases system in endothelium-dependent hyperpolarization in mice J. Exp. Med., August 11, 2008; (2008) jem.20080106. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sasaki, T. Yamashita, T. Takaya, M. Shinohara, R. Shiraki, M. Takeda, N. Emoto, A. Fukatsu, T. Hayashi, K. Ikemoto, et al. Augmentation of Vascular Remodeling by Uncoupled Endothelial Nitric Oxide Synthase in a Mouse Model of Diabetes Mellitus Arterioscler. Thromb. Vasc. Biol., June 1, 2008; 28(6): 1068 - 1076. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. T. Gao, L. J. Roman, P. Martasek, S. P. Panda, Y. Ishimura, and B. S. S. Masters Oxygen Metabolism by Endothelial Nitric-oxide Synthase J. Biol. Chem., September 28, 2007; 282(39): 28557 - 28565. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |